HuGE Literature Finder
Records 1-30
|
Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population.
European journal of clinical pharmacology 2018 Feb . Ajmi Marwa, Omezzine Asma, Achour Slim, Amor Dorra, Hamdouni Haithem, Ismaïl Fatma Ben Fredj, Rejeb Nabila Ben, Kechrid Chedia Laouani, Boughzela Essia, Bouslama A |
|
Meta-Analysis of Genotype-Guided Versus Standard Dosing of Vitamin K Antagonists.
The American journal of cardiology 2018 Jan . Kheiri Babikir, Abdalla Ahmed, Haykal Tarek, Osman Mohammed, Ahmed Sahar, Hassan Mustafa, Bachuwa Ghass |
|
Association Between the Lower Extremity Deep Venous Thrombosis, the Warfarin Maintenance Dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 Genetic Polymorphisms: A Case-Control Study.
Genetic testing and molecular biomarkers 2017 Sep . Ju Shang, Gao Yu, Cao Xin, Zhang Xiao-Fu, Yan Cheng-Cheng, Liu Feng-To |
|
Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study.
Balkan journal of medical genetics : BJMG 2017 Jun 20 (1): 35-42. Dambrauskien? R, Gerbutavi?ius R, Ugenskien? R, Jankauskait? R, Savukaityt? A, Šimoli?nien? R, Rudžianskien? M, Gerbutavi?ien? R, Juozaityt? |
|
Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2017 Apr . Park Yun Kyung, Lee Mi Ji, Kim Jae Ha, Lee Jin Soo, Park Rae Woong, Kim Gyeong-Moon, Chung Chin-Sang, Lee Kwang Ho, Kim June Soo, Lee Soo-Youn, Bang Oh You |
|
Predictors of warfarin dose requirements in South African patients attending an anticoagulation clinic.
Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing 2017 Mar 35 (1): 27-30. Schapkaitz Elise, Sithole Johan |
|
Warfarin dose requirements with different genotypes of CYP2C9 and VKORC1 for patients with atrial fibrillation and valve replacement.
International journal of clinical pharmacology and therapeutics 2017 02 55 (2): 126-132. Chen Weirong, Wu Luhua, Liu Xin, Shen Yue, Liang Yan, Zhu Jun, Tan Huiqiong, Yang Yanmin, Liu Qun, Wang Mingsheng, Liu Lisheng, Wang Xing |
|
Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.
Oncotarget 2016 Jul . Min-Gu Kang, Hyun-Woo Choi, Jun Hyung Lee, Yong Jun Choi, Hyun-Jung Choi, Jong-Hee Shin, Soon-Pal Suh, Szardenings Michael, Hye-Ran Kim, Myung-Geun Sh |
|
Co-occurrence of myeloproliferative neoplasms and solid tumors is attributed to a synergism between cytoreductive therapy and the common TERT polymorphism rs2736100.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Oct . Krahling Tunde, Balassa Katalin, Kiss Katalin P, Bors Andras, Batai Arpad, Halm Gabriella, Egyed Miklos, Fekete Sandor, Remenyi Peter, Masszi Tamas, Tordai Attila, Andrikovics Hajnal |
|
Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.
Journal of cardiovascular pharmacology and therapeutics 2015 Jul 20 (4): 387-94. Tang Tao, Liu Jie, Zuo Keqiang, Cheng Jie, Chen Linyin, Lu Chenhui, Han Shilong, Xu Jichong, Jia Zhongzhi, Ye Meng, Pei Erli, Zhang Xiaoping, Li Maoqu |
|
Influence of UDP-glucuronosyltransferase polymorphisms on stable warfarin doses in patients with mechanical cardiac valves.
Cardiovascular therapeutics 2015 Jul . An Sook Hee, Chang Byung Chul, Lee Kyung Eun, Gwak Hye S |
|
The Influence of VKORC1 Polymorphisms on Warfarin Doses in Thai Patients with Deep Vein Thrombosis.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2015 Jun 98 (6): 549-54. Sermsathanasawadi Nuttawut, Sritongsathian Chukij, Pongrattanaman Nunthapol, Praditsuktavorn Banjerd, Hongku Kiattisak, Wongwanit Chumpol, Ruangsetakit Chanean, Chinsakchai Khamin, Mutirangura Pramook, Poungvarin Narav |
|
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.
Leukemia research 2015 May 39 (5): 525-9. Gianelli Umberto, Iurlo Alessandra, Cattaneo Daniele, Bossi Anna, Cortinovis Ivan, Augello Claudia, Moro Alessia, Savi Federica, Castelli Roberto, Brambilla Cecilia, Bianchi Paola, Primignani Massimo, Cortelezzi Agostino, Bosari Silva |
|
[Comparison of Empiric and Pharmacogenetic Approaches in Assessment of Efficacy of Anticoagulant Therapy].
Kardiologiia 2015 55 (4): 57-60. Kokh N V, Slepukhina A A, Tsvetovskaya G A, Lifshits G |
|
VKORC1 and CYP2C9 genotypic data-based dose prediction alone does not accurately predict warfarin dose requirements in some Malaysian patients.
Turkish journal of medical sciences 2015 45 (4): 913-8. Chua Yung An, Abdullah Wan Zaidah, Yusof Zurkurnai, Gan Siew H |
|
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis.
Journal of thrombosis and haemostasis : JTH 2014 Sep 12 (9): 1480-7. Franchini M, Mengoli C, Cruciani M, Bonfanti C, Mannucci P |
|
Factors affecting warfarin dose requirements and quality of anticoagulation in adult Egyptian patients: role of gene polymorphism.
Irish journal of medical science 2014 Jun 183 (2): 161-72. Bazan N S, Sabry N A, Rizk A, Mokhtar S, Badary O |
|
A pharmacogenetic versus a clinical algorithm for warfarin dosing.
The New England journal of medicine 2013 Dec 369 (24): 2283-93. Kimmel Stephen E, French Benjamin, Kasner Scott E, Johnson Julie A, Anderson Jeffrey L, Gage Brian F, Rosenberg Yves D, Eby Charles S, Madigan Rosemary A, McBane Robert B, Abdel-Rahman Sherif Z, Stevens Scott M, Yale Steven, Mohler Emile R, Fang Margaret C, Shah Vinay, Horenstein Richard B, Limdi Nita A, Muldowney James A S, Gujral Jaspal, Delafontaine Patrice, Desnick Robert J, Ortel Thomas L, Billett Henny H, Pendleton Robert C, Geller Nancy L, Halperin Jonathan L, Goldhaber Samuel Z, Caldwell Michael D, Califf Robert M, Ellenberg Jonas H, |
|
A randomized trial of genotype-guided dosing of warfarin.
The New England journal of medicine 2013 Dec 369 (24): 2294-303. Pirmohamed Munir, Burnside Girvan, Eriksson Niclas, Jorgensen Andrea L, Toh Cheng Hock, Nicholson Toby, Kesteven Patrick, Christersson Christina, Wahlström Bengt, Stafberg Christina, Zhang J Eunice, Leathart Julian B, Kohnke Hugo, Maitland-van der Zee Anke H, Williamson Paula R, Daly Ann K, Avery Peter, Kamali Farhad, Wadelius Mia, |
|
Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial.
Trials 2012 Dec 13 (1): 1. Carcas AJ, Borobia AM, Velasco M, Abad-Santos F, Díaz MQ, Fernández-Capitán C, Ruiz-Giménez N, Madridano O, Sillero PL |
|
Prevalence of VKORC1 and CYP2C9 gene polymorphisms in Indian population and its effect on warfarin response.
The Journal of the Association of Physicians of India 2012 Dec 60 34-8. Shalia Kavita K, Doshi Shripal M, Parikh Suhas, Pawar Poonam P, Divekar Siddhi S, Varma Sandeep P, Mehta Rachna, Doctor Tasneem, Shah Vinod K, Saranath |
|
CYP2C9 and VKORC1 Gene Polymorphism is Inessential for Bleeding Development under Conditions of Oral Application of Anticoagulant Acenocoumarol in Russian Patients at High Risk of Thromboembolic Complications.
Bulletin of experimental biology and medicine 2012 Oct 153 (6): 6. Sychev DV, Ignatyev IV, Emelyanov NV, Milovanova VV, Kossovskaya AV, Kukes IV, Tashenova AI, Kukes VG |
|
A new algorithm to predict warfarin dose from polymorphisms of CYP4F2 , CYP2C9 and VKORC1 and clinical variables: derivation in Han Chinese patients with non valvular atrial fibrillation.
Thrombosis and haemostasis 2012 Jun 107 (6): 1083-91. Wei Meng, Ye Fei, Xie Dujiang, Zhu Yubing, Zhu Junrong, Tao Yifu, Yu Fe |
|
JAK2 V617F Mutation Prevalence in Myeloproliferative Neoplasms in Pernambuco, Brazil.
Genetic testing and molecular biomarkers 2012 Feb . Silva RR, Domingues Hatzlhofer BL, Machado CG, Lima AS, Albuquerque DM, Santos MN, Fertrin KY, Costa FF, Araújo AD, Bezerra MA |
|
Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in Chinese valve replacement patients.
Journal of cardiothoracic surgery 2012 7 (1): 97. Li Jie-Hui, Ma Guo-Guo, Zhu Shu-Qiang, Yan Hao, Wu Yong-Bing, Xu Jian-J |
|
Influence of CYP2C9 and VKORC1 polymorphisms on warfarin and acenocoumarol in a sample of Lebanese people.
Journal of clinical pharmacology 2011 Oct 51 (10): 1418-28. Esmerian Maria O, Mitri Zahi, Habbal Mohammad-Zuheir, Geryess Eddy, Zaatari Ghazi, Alam Samir, Skouri Hadi N, Mahfouz Rami A, Taher Ali, Zgheib Nathalie |
|
[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2011 Aug 19 (4): 916-20. Zhu Jun-Fang, Liu Yuan, Liu Pei, Jia Ming-Feng, Cheng Juan, Zhao |
|
Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome.
Thrombosis research 2011 Jun 127 (6): 595-9. Ames Paul R J, Margaglione Maurizio, Ciampa Antonio, Colaizzo Donatella, Ferrara Felicetto, Iannaccone Luigi, Vincenzobrancacci |
|
Algorithms using clinical and genetic data (CYP2C9, VKORC1) are relevant to predict warfarin dose in patients with different INR targets.
Thrombosis research 2010 Sep 126 (3): e235-7. Le Cam-Duchez Véronique, Frétigny Mathilde, Cailleux Nicole, Gandelin Catherine, Lévesque Hervé, Borg Jeanne-Yvon |
|
Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.
Journal of thrombosis and haemostasis : JTH 2010 Jan 8 (1): 95-100. Ferder N S, Eby C S, Deych E, Harris J K, Ridker P M, Milligan P E, Goldhaber S Z, King C R, Giri T, McLeod H L, Glynn R J, Gage B |
|
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis.
Leukemia 2009 May 23 (5): 905-11. Tefferi A, Pardanani A, Lim K-H, Abdel-Wahab O, Lasho T L, Patel J, Gangat N, Finke C M, Schwager S, Mullally A, Li C-Y, Hanson C A, Mesa R, Bernard O, Delhommeau F, Vainchenker W, Gilliland D G, Levine R |
|
A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists.
Journal of applied genetics 2009 50 (4): 399-403. Stepien E, Branicka A, Ciesla-Dul M, Undas |
|
Oral anticoagulation with warfarin is significantly influenced by steroids and CYP2C9 polymorphisms in children with cancer.
Pediatric blood & cancer 2008 Mar 50 (3): 710-3. Ruud Ellen, Holmstrøm Henrik, Bergan Stein, Wesenberg Fi |
|
Frequency of CYP2C9 polymorphisms affecting warfarin metabolism in a large anticoagulant clinic cohort.
Clinical biochemistry 2006 Jun 39 (6): 606-12. Moridani Majid, Fu Lei, Selby Rita, Yun Francisco, Sukovic Tatjana, Wong Betty, Cole David E |
- Page last reviewed:Mar 16, 2019
- Page last updated:Jul 01, 2020
- Content source: